Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Infiltrating Lymphocytes”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Very early researchLooking for participantsNCT05087745
What this trial is testing

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorTumor Infiltrating LymphocytesTreatment Side Effects+1 more
Shanghai Juncell Therapeutics 50
Very early researchUnknownNCT03347097
What this trial is testing

Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Huashan Hospital 40
Early research (Phase 1)Study completedNCT03158935
What this trial is testing

The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

Who this might be right for
Advanced Ovarian CancerMalignant Melanoma
University Health Network, Toronto 8
Testing effectiveness (Phase 2)Study completedNCT00062036
What this trial is testing

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 33
Testing effectiveness (Phase 2)Study completedNCT02493361
What this trial is testing

Trial of pIL-12/MK-3475 in Metastatic Melanoma

Who this might be right for
Melanoma
University of California, San Francisco 24
Not applicableLooking for participantsNCT06235242
What this trial is testing

GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Cancer

Who this might be right for
AdultNon-small Cell Lung Cancer
Grit Biotechnology 20
Very early researchUnknownNCT04919616
What this trial is testing

An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Shanghai OriginCell Therapeutics Co., Ltd. 15
Testing effectiveness (Phase 2)Looking for participantsNCT05645380
What this trial is testing

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Who this might be right for
Triple Negative Breast CancerBreast Cancer
University of Kansas Medical Center 139
Not applicableEnded earlyNCT04341740
What this trial is testing

Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaUrothelial Carcinoma
University of Oklahoma 6
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Not applicableEnrolling By InvitationNCT05600933
What this trial is testing

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Who this might be right for
Solid TumorsHematologic MalignancyGastrointestinal Cancer+5 more
National Cancer Institute (NCI) 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07288073
What this trial is testing

TIL Therapy in cSCC and MCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaMetastatic Cutaneous Squamous Cell Carcinoma+1 more
Karam Khaddour, MD, MS 14
Early research (Phase 1)UnknownNCT01462903
What this trial is testing

Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Nasopharyngeal CarcinomaHepatocellular CarcinomaBreast Carcinoma
Sun Yat-sen University 20
Testing effectiveness (Phase 2)Study completedNCT06120712
What this trial is testing

GC101 TIL in Advanced Melanoma (BZ)

Who this might be right for
Tumor Infiltrating LymphocytesSafetyMelanoma+2 more
Shanghai Juncell Therapeutics 18
Testing effectiveness (Phase 2)Looking for participantsNCT06455917
What this trial is testing

TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-Small Cell Lung CancerLung Cancer (NSCLC)
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)Looking for participantsNCT03467516
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

Who this might be right for
Uveal NeoplasmsMelanoma, Uveal
Udai Kammula 47
Not applicableLooking for participantsNCT04622423
What this trial is testing

Advanced Therapies for Liver Metastases

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Liver Metastasis
IRCCS San Raffaele 475
Not applicableActive Not RecruitingNCT05157659
What this trial is testing

[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer.

Who this might be right for
Non-Small Cell Lung Cancer
Amsterdam UMC, location VUmc 10
Not applicableStudy completedNCT06965361
What this trial is testing

Stromal Tumor-Infiltrating Lymphocyte Levels Are Associated With Immune Checkpoint Proteins In Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
Ziauddin University 54
Load More Results